Remarkably, the abundance of TIICs, including CD8+, CD4+, CD68+, CD20+ and CD66b+ cells, significantly increased with the increase in CPS, indicating a ‘hotter’ tumour immune environment. The gene discussed is CD4; the disease is neoplasm.